Shimada, Y., Kudo, Y., Maehara, S., Matsubayashi, J., Otaki, Y., Kajiwara, N., . . . Ikeda, N. (2020). Ubiquitin C‐terminal hydrolase‐L1 has prognostic relevance and is a therapeutic target for high‐grade neuroendocrine lung cancers. Cancer Sci.
Citação norma ChicagoShimada, Yoshihisa, Yujin Kudo, Sachio Maehara, Jun Matsubayashi, Yoichi Otaki, Naohiro Kajiwara, Tatsuo Ohira, John D. Minna, and Norihiko Ikeda. "Ubiquitin C‐terminal Hydrolase‐L1 Has Prognostic Relevance and Is a Therapeutic Target for High‐grade Neuroendocrine Lung Cancers." Cancer Sci 2020.
ציטוט MLAShimada, Yoshihisa, et al. "Ubiquitin C‐terminal Hydrolase‐L1 Has Prognostic Relevance and Is a Therapeutic Target for High‐grade Neuroendocrine Lung Cancers." Cancer Sci 2020.